{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:15:03Z","timestamp":1793582103678,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T00:00:00Z","timestamp":1411430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/mp.2014.110","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T08:52:55Z","timestamp":1411462375000},"page":"1017-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Imaging of activated complement using ultrasmall superparamagnetic iron oxide particles (USPIO) - conjugated vectors: an in vivo in utero non-invasive method to predict placental insufficiency and abnormal fetal brain development"],"prefix":"10.1038","volume":"20","author":[{"given":"G","family":"Girardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lennen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Vontell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hutchison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,23]]},"reference":[{"key":"BFmp2014110_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.siny.2006.03.005","volume":"11","author":"M Elovitz","year":"2006","unstructured":"Elovitz M . Anti-inflammatory interventions in pregnancy: now and the future. Semin Fetal Neonatal Med 2006; 11: 327\u2013332.","journal-title":"Semin Fetal Neonatal Med"},{"key":"BFmp2014110_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aji.12000","volume":"69","author":"KJ Denny","year":"2013","unstructured":"Denny KJ, Woodruff TM, Taylor SM, Callaway LK . Complement in pregnancy: a delicate balance. Am J Reprod Immunol 2013; 69: 3\u201311.","journal-title":"Am J Reprod Immunol"},{"key":"BFmp2014110_CR3","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/j.molimm.2011.04.011","volume":"48","author":"G Girardi","year":"2011","unstructured":"Girardi G, Proh\u00e1szka Z, Bulla R, Tedesco F, Scherjon S . Complement activation in animal and human pregnancies as a model for immunological recognition. Mol Immunol 2011; 48: 1621\u20131630.","journal-title":"Mol Immunol"},{"key":"BFmp2014110_CR4","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.ajpath.2011.04.024","volume":"179","author":"JM Gonzalez","year":"2011","unstructured":"Gonzalez JM, Franzke CW, Yang F, Romero R, Girardi G . Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. Am J Pathol 2011; 179: 838\u2013849.","journal-title":"Am J Pathol"},{"key":"BFmp2014110_CR5","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1172\/JCI200318817","volume":"112","author":"G Girardi","year":"2003","unstructured":"Girardi G, Berman J, Redecha P, Spruce L, Thurman JM, Kraus D et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 2003; 112: 1644\u20131654.","journal-title":"J Clin Invest"},{"key":"BFmp2014110_CR6","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1177\/0961203312444172","volume":"21","author":"S De Carolis","year":"2012","unstructured":"De Carolis S, Botta A, Santucci S, Salvi S, Moresi S, Di Pasquo E et al. Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. Lupus 2012; 21: 776\u2013778.","journal-title":"Lupus"},{"key":"BFmp2014110_CR7","doi-asserted-by":"publisher","first-page":"e16806","DOI":"10.1371\/journal.pone.0016806","volume":"6","author":"J Lee","year":"2011","unstructured":"Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One 2011; 6: e16806.","journal-title":"PLoS One"},{"key":"BFmp2014110_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbadis.2013.10.011","volume":"1842","author":"SM Pedroni","year":"2014","unstructured":"Pedroni SM, Gonzalez JM, Wade J, Jansen MA, Serio A, Marshall I et al. Complement inhibition and statins prevent fetal brain cortical abnormalities in a mouse model of preterm birth. Biochim Biophys Acta 2014; 1842: 107\u2013115.","journal-title":"Biochim Biophys Acta"},{"key":"BFmp2014110_CR9","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.semarthrit.2013.07.001","volume":"43","author":"N Abisror","year":"2013","unstructured":"Abisror N, Mekinian A, Lachassinne E, Nicaise-Roland P, De Pontual L, Chollet-Martin S et al. Autism spectrum disorders in babies born to mothers with antiphospholipid syndrome. Semin Arthritis Rheum 2013; 43: 348\u2013351.","journal-title":"Semin Arthritis Rheum"},{"key":"BFmp2014110_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1177\/0961203312446387","volume":"21","author":"M Motta","year":"2012","unstructured":"Motta M, Boffa MC, Tincani A, Avcin T, De Carolis S, Lachassinne E . Follow-up of babies born to mothers with antiphospholipid syndrome: preliminary data from the European neonatal registry. Lupus 2012; 21: 761\u2013763.","journal-title":"Lupus"},{"key":"BFmp2014110_CR11","doi-asserted-by":"publisher","first-page":"F355","DOI":"10.1136\/adc.2010.195099","volume":"96","author":"M Motta","year":"2011","unstructured":"Motta M, Zambelloni C, Rodriguez-Perez C, Angeli A, Lojacono A, Tincani A et al. Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease. Arch Dis Child Fetal Neonatal Ed 2011; 96: F355\u2013F358.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"BFmp2014110_CR12","first-page":"35","volume":"1","author":"YX Wang","year":"2011","unstructured":"Wang YX . Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 2011; 1: 35\u201340.","journal-title":"Quant Imaging Med Surg"},{"key":"BFmp2014110_CR13","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.4049\/jimmunol.156.7.2631","volume":"156","author":"M Monestier","year":"1996","unstructured":"Monestier M, Kandiah DA, Kouts S, Novick KE, Ong GL, Radic MZ et al. Monoclonal antibodies from NZW x BXSB F1 mice to beta2 glycoprotein I and cardiolipin: species specificity and charge-dependent binding. J Immunol 1996; 156: 2631\u20132641.","journal-title":"J Immunol"},{"key":"BFmp2014110_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.molimm.2003.10.019","volume":"40","author":"D Mastellos","year":"2004","unstructured":"Mastellos D, Prechl J, L\u00e1szl\u00f3 G, Papp K, Ol\u00e1h E, Argyropoulos E et al. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol Immunol 2004; 40: 1213\u20131221.","journal-title":"Mol Immunol"},{"key":"BFmp2014110_CR15","first-page":"27","volume":"1","author":"F Shamsipour","year":"2009","unstructured":"Shamsipour F, Zarnani AH, Ghods R, Chamankhah M, Forouzesh F, Vafaei S et al. Conjugation of monoclonal antibodies and rat IgG1 to super paramagnetic iron oxide nanoparticles for detection of her2\/neu antigen on breast cancer cell lines. Avicenna J Med Biotech 2009; 1: 27\u201331.","journal-title":"Avicenna J Med Biotech"},{"key":"BFmp2014110_CR16","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2217\/nnm.12.81","volume":"7","author":"XM Zhu","year":"2012","unstructured":"Zhu XM, Wang YX, Leung KC, Lee SF, Zhao F, Wang DW et al. Enhanced cellular uptake of aminosilane coated superparamagnetic iron oxide nanoparticles in mammalian cell lines. Int J Nanomedicine 2012; 7: 953\u2013964.","journal-title":"Int J Nanomedicine"},{"key":"BFmp2014110_CR17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1097\/01.ASN.0000051597.27127.A1","volume":"14","author":"L Bao","year":"2003","unstructured":"Bao L, Haas M, Kraus DM, Hack BK, Rakstang JK, Holers VM et al. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL\/lpr mice. J Am Soc Nephrol 2003; 14: 670\u2013679.","journal-title":"J Am Soc Nephrol"},{"key":"BFmp2014110_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0006-8993(96)01387-X","volume":"751","author":"LC Schmuel","year":"1997","unstructured":"Schmuel LC, Alberston C, Slikker W Jr . Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 1997; 751: 37\u201347.","journal-title":"Brain Res"},{"key":"BFmp2014110_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/978-1-61779-328-8_4","volume":"793","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Magran\u00e9 J . Isolation and culture of neurons and astrocytes from the mouse brain cortex. Methods Mol Biol 2011; 793: 63\u201375.","journal-title":"Methods Mol Biol"},{"key":"BFmp2014110_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/path.2893","volume":"225","author":"D Cohen","year":"2011","unstructured":"Cohen D, Buurma A, Goemaere NN, Girardi G, le Cessie S, Scherjon S et al. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss. J Pathol 2011; 225: 502\u2013511.","journal-title":"J Pathol"},{"key":"BFmp2014110_CR21","first-page":"321","volume":"6","author":"K Yamashita","year":"2011","unstructured":"Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M et al. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Biotechnol 2011; 6: 321\u2013328.","journal-title":"Nat Biotechnol"},{"key":"BFmp2014110_CR22","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0140-6736(05)71048-5","volume":"365","author":"JE Lawn","year":"2005","unstructured":"Lawn JE, Cousens S, Zupan J . 4 million neonatal deaths: when? Where? Why? Lancet 2005; 365: 891\u2013900.","journal-title":"Lancet"},{"key":"BFmp2014110_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","volume":"8","author":"JJ Volpe","year":"2009","unstructured":"Volpe JJ . Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8: 110\u2013124.","journal-title":"Lancet Neurol"},{"key":"BFmp2014110_CR24","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"BFmp2014110_CR25","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/acr.22066","volume":"65","author":"L Andreoli","year":"2013","unstructured":"Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, Ramire de Jesus G, Erkan D . Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis Care Res (Hoboken) 2013; 65: 1869\u20131873.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"BFmp2014110_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nri2529","volume":"9","author":"D Diamond","year":"2009","unstructured":"Diamond D, Huerta PT, Mina-Osorio P, Kowal C, Volpe BT . Losing your nerves? Maybe it\u2019s the antibodies. Nat Rev Immunol 2009; 9: 449\u2013456.","journal-title":"Nat Rev Immunol"},{"key":"BFmp2014110_CR27","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","volume":"110","author":"P Redecha","year":"2007","unstructured":"Redecha P, Tilley R, Tencati M, Salmon JE, Kirchhofer D, Mackman N et al. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury. Blood 2007; 110: 2423\u20132431.","journal-title":"Blood"},{"key":"BFmp2014110_CR28","doi-asserted-by":"publisher","first-page":"3258","DOI":"10.1016\/j.vaccine.2006.01.026","volume":"24","author":"U Heininger","year":"2006","unstructured":"Heininger U, Desgrandchamps D, Schaad UB . Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine 2006; 24: 3258\u20133260.","journal-title":"Vaccine"},{"key":"BFmp2014110_CR29","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1002\/dneu.22052","volume":"72","author":"E Fox","year":"2012","unstructured":"Fox E, Amaral D, Van de Waters J . Maternal and fetal anti-brain antibodies in development and diseases. Dev Neurobiol 2012; 72: 1327\u20131334.","journal-title":"Dev Neurobiol"},{"key":"BFmp2014110_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S0022-3476(99)70458-0","volume":"134","author":"JK Grether","year":"1999","unstructured":"Grether JK, Nelson KB, Dambrosia JM, Phillips TM . Interferons and cerebral palsy. J Pediatr 1999; 134: 324\u2013332.","journal-title":"J Pediatr"},{"key":"BFmp2014110_CR31","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0361-9230(97)00408-5","volume":"45","author":"US Vasthare","year":"1998","unstructured":"Vasthare US, Barone FC, Sarau HM, Rosenwasser RH, DiMartino M, Young WF et al. Complement depletion improves neurological function in cerebral ischemia. Brain Res Bull 1998; 45: 413\u2013419.","journal-title":"Brain Res Bull"},{"key":"BFmp2014110_CR32","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2005.01.027","volume":"380","author":"E Figueroa","year":"2005","unstructured":"Figueroa E, Gordon LE, Feldhoff PW, Lassiter HA . The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats. Neurosci Lett 2005; 380: 48\u201353.","journal-title":"Neurosci Lett"},{"key":"BFmp2014110_CR33","doi-asserted-by":"publisher","first-page":"9459","DOI":"10.1523\/JNEUROSCI.23-28-09459.2003","volume":"23","author":"RM Cowell","year":"2003","unstructured":"Cowell RM, Plane JM, Silverstein FS . Complement activation contributes to hypoxic-ischemic brain injury in neonatal rats. J Neurosci 2003; 23: 9459\u20139468.","journal-title":"J Neurosci"},{"key":"BFmp2014110_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0361-9230(99)00004-0","volume":"48","author":"SM Lew","year":"1999","unstructured":"Lew SM, Gross CE, Bednar MM, Russell SJ, Fuller SP, Ellenberger C et al. Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke. Brain Res Bull 1999; 48: 325\u2013331.","journal-title":"Brain Res Bull"},{"key":"BFmp2014110_CR35","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0304-3940(01)01653-6","volume":"302","author":"HA Lassiter","year":"2001","unstructured":"Lassiter HA, Feldhoff RC, Dabhia N, Parker JC Jr, Feldhoff PW . Complement inhibition does not reduce post-hypoxic-ischemic cerebral injury in 21-day-old rats. Neurosci Lett 2001; 302: 37\u201340.","journal-title":"Neurosci Lett"},{"key":"BFmp2014110_CR36","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1096\/fj.13-230011","volume":"27","author":"K J\u00e4rlestedt","year":"2013","unstructured":"J\u00e4rlestedt K, Rousset CI, St\u00e5hlberg A, Sourkova H, Atkins AL, Thornton C et al. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury. FASEB J 2013; 27: 3797\u20133804.","journal-title":"FASEB J"},{"key":"BFmp2014110_CR37","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1056\/NEJMoa072972","volume":"358","author":"CW Hoge","year":"2008","unstructured":"Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA . Mild traumatic brain injury in U.S. soldiers returning from Iraq. N Engl J Med 2008; 358: 453\u2013463.","journal-title":"N Engl J Med"},{"key":"BFmp2014110_CR38","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1172\/JCI119572","volume":"100","author":"L Ziporen","year":"1997","unstructured":"Ziporen L, Shoenfeld Y, Levy Y, Korczyn AD . Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model. J Clin Invest 1997; 100: 613\u2013619.","journal-title":"J Clin Invest"},{"key":"BFmp2014110_CR39","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ki.2011.332","volume":"81","author":"SA Sargsyan","year":"2012","unstructured":"Sargsyan SA, Serkova NJ, Renner B, Hasebroock KM, Larsen B, Stoldt C et al. Detection of glomerular complement C3 fragments by magnetic resonance imaging in murine lupus nephritis. Kidney Int 2012; 81: 152\u2013159.","journal-title":"Kidney Int"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/mp2014110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2014110","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/mp2014110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T18:34:19Z","timestamp":1689532459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/mp2014110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,23]]},"references-count":39,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["BFmp2014110"],"URL":"https:\/\/doi.org\/10.1038\/mp.2014.110","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,23]]},"assertion":[{"value":"28 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}